Literature DB >> 28385290

Post-prandial systemic 8-isoprostane increases after consumption of moderate and high-fat meals in insufficiently active males.

S P Kurti1, S R Emerson2, S K Rosenkranz3, C S Teeman4, E M Emerson5, B J Cull6, J R Smith7, C A Harms8.   

Abstract

A single high-fat meal (HFM) leads to an increase in triglycerides and oxidative stress. Oxidative stress can be assessed via 8-isoprostane generation, which is associated with the development of asthma and cardiovascular disease. No previous research has investigated whether airway and systemic 8-isoprostane increases postprandially in nonasthmatic participants according to the energy and fat content of a meal. Our purpose was to assess airway and systemic 8-isoprostane after a HFM and a true-to-life moderate-fat meal (MFM). We hypothesized that airway and systemic 8-isoprostane would increase after a HFM and a MFM, with the greatest increase in the HFM condition. Eight nonasthmatic men (25.8±6.9years) completed the HFM and MFM trials in a randomized crossover design. After a 10-hour fast, participants consumed either a HFM (71.13kJ/kg body mass, 60% fat, 23% CHO) or a MFM (35.56kJ/kg body mass, 30% fat, 52% CHO). Exhaled breath condensate to assess airway 8-isoprostane was collected at baseline and at 3 and 6hours postmeal. Venous blood samples were collected at baseline and hourly until 6hours postmeal to assess triglycerides, and every 3hours for systemic 8-isoprostane. Airway 8-isoprostane responses were not significant as a main effect of time (P=.072), between conditions (P=.365), or between time and condition (P=.319) postmeal. Systemic 8-isoprostane increased over time (P<.001), but not between conditions (P=.124) or between time and condition (P=.649) postmeal. Triglyceride incremental area under the curve was different in the HFM compared to the MFM condition (P=.013). After a HFM and a MFM, 8-isoprostane increases systemically; however, airway 8-isoprostane does not change.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease risk; Oxidative stress; Randomized crossover design; Triglycerides

Mesh:

Substances:

Year:  2017        PMID: 28385290     DOI: 10.1016/j.nutres.2017.02.003

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  5 in total

Review 1.  Inflammation and oxidative stress as mediators of the impacts of environmental exposures on human pregnancy: Evidence from oxylipins.

Authors:  Barrett M Welch; Erin E McNell; Matthew L Edin; Kelly K Ferguson
Journal:  Pharmacol Ther       Date:  2022-04-01       Impact factor: 13.400

2.  Evaluation of Agraz Consumption on Adipocytokines, Inflammation, and Oxidative Stress Markers in Women with Metabolic Syndrome.

Authors:  Juliana Espinosa-Moncada; Catalina Marín-Echeverri; Yeisson Galvis-Pérez; Gelmy Ciro-Gómez; Juan C Aristizábal; Christopher N Blesso; Maria Luz Fernandez; Jacqueline Barona-Acevedo
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

3.  Three-Year Study of Markers of Oxidative Stress in Exhaled Breath Condensate in Workers Producing Nanocomposites, Extended by Plasma and Urine Analysis in Last Two Years.

Authors:  Daniela Pelclova; Vladimir Zdimal; Martin Komarc; Jaroslav Schwarz; Jakub Ondracek; Lucie Ondrackova; Martin Kostejn; Stepanka Vlckova; Zdenka Fenclova; Stepanka Dvorackova; Lucie Lischkova; Pavlina Klusackova; Viktoriia Kolesnikova; Andrea Rossnerova; Tomas Navratil
Journal:  Nanomaterials (Basel)       Date:  2020-12-06       Impact factor: 5.076

4.  Postprandial changes of oxidative stress biomarkers in healthy individuals.

Authors:  Fengyi Huang; Xue Shen; Yuzheng Zhang; Ann M Vuong; Shuman Yang
Journal:  Front Nutr       Date:  2022-09-30

5.  Reference Ranges of 8-Isoprostane Concentrations in Exhaled Breath Condensate (EBC): A Systematic Review and Meta-Analysis.

Authors:  Yara Shoman; Pascal Wild; Maud Hemmendinger; Melanie Graille; Jean-Jacques Sauvain; Nancy B Hopf; Irina Guseva Canu
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.